Compass Government Relations Partners, LLC

GOVERNMENT BUSINESS

Mendix | September 01, 2021

Vital Edge Solutions, a specialist in systems integration for government and commercial organizations, today announced that it has entered a strategic partnership with Mendix, a Siemens business and the global leader in low-code application development for enterprises, to bring low-code to the Federal Marketplace. This is Mendix's first partnership within the US Federal Marketplace and comes at a time when the industry is experiencing an unprecedented growth in interest surrounding low-code ...

Nextgov | January 28, 2020

The State Department has a poor track record when it comes to deploying IT. But all that is about to change, according to the agency’s chief information officer, who is in the midst of reengineering the way the department does IT. When Stuart McGuigan joined the State Department in March, he found a large organization with a multitude of missions, outposts and, importantly, technology needs. McGuigan—who came from a private-sector background managing IT for large companies—want...

The Hill | March 19, 2020

Aviation industry groups are urging the federal government to quickly address the impact of the coronavirus on airlines, saying the current economic environment is not sustainable. Airlines for America (A4A) and others in the aviation industry wrote to the Treasury Secretary Steven Mnuchin and congressional leadership on Thursday requesting immediate action. “The breadth and immediacy of the need to act cannot be overstated. It is urgent and unprecedented,” the letter reads. The lett...

JOHNSON & JOHNSON | March 31, 2020

The Trump administration has made another move in the race to combat and stop the viral outbreak of COVID-19, also known as the coronavirus, around the globe. The Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) recently signed a deal for a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen. The order has been specified as a “new vaccine asset for 2019 Novel Coronavirus (COVID-19).” It is the largest amoun...